LSCs exhibited higher PRDX1 expression levels (median MFIR = 31.5) than non-LSCs (median MFIR = 30.9) in patients with AML (n = 6), although the difference was not statistically significant (Fig. S7C). The gene discussed is PRDX1; the disease is acute myeloid leukemia.